211 related articles for article (PubMed ID: 26218492)
41. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
[TBL] [Abstract][Full Text] [Related]
42. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
43. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
44. Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination.
Ozyer S; Uzunlar O; Ozler S; Kaymak O; Baser E; Gungor T; Mollamahmutoglu L
Asian Pac J Cancer Prev; 2013; 14(8):4877-81. PubMed ID: 24083762
[TBL] [Abstract][Full Text] [Related]
45. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
46. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
Almobarak AO; Elbadawi AA; Elmadhoun WM; Elhoweris MH; Ahmed MH
Asian Pac J Cancer Prev; 2016; 17(2):625-30. PubMed ID: 26925654
[TBL] [Abstract][Full Text] [Related]
47. Cervical screening in HPV-vaccinated populations.
Canfell K
Climacteric; 2018 Jun; 21(3):227-234. PubMed ID: 29565690
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.
Kudo R; Sekine M; Yamaguchi M; Hara M; Hanley SJB; Kurosawa M; Adachi S; Ueda Y; Miyagi E; Ikeda S; Yagi A; Enomoto T
Cancer Sci; 2022 Sep; 113(9):3211-3220. PubMed ID: 35730321
[TBL] [Abstract][Full Text] [Related]
50. Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial.
Elfström KM; Eklund C; Lamin H; Öhman D; Hortlund M; Elfgren K; Sundström K; Dillner J
PLoS Med; 2021 Aug; 18(8):e1003748. PubMed ID: 34424907
[TBL] [Abstract][Full Text] [Related]
51. Mortality of non-participants in cervical screening: Register-based cohort study.
Dugué PA; Lynge E; Rebolj M
Int J Cancer; 2014 Jun; 134(11):2674-82. PubMed ID: 24288241
[TBL] [Abstract][Full Text] [Related]
52. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
53. [The follow up of the women vaccinated against HPV].
Riethmuller D; Ramanah R; Carcopino X; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2013 Oct; 42(6):525-33. PubMed ID: 23669416
[TBL] [Abstract][Full Text] [Related]
54. Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S.
Kulasingam SL; Pagliusi S; Myers E
Vaccine; 2007 Nov; 25(48):8110-3. PubMed ID: 17961877
[TBL] [Abstract][Full Text] [Related]
55. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
56. High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study.
Thamsborg LH; Napolitano G; Larsen LG; Lynge E
Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1290-1296. PubMed ID: 32754966
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
58. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
59. Knowledge and acceptability of human papillomavirus vaccination and cervical cancer screening among women in Karnataka, India.
Montgomery MP; Dune T; Shetty PK; Shetty AK
J Cancer Educ; 2015 Mar; 30(1):130-7. PubMed ID: 25355525
[TBL] [Abstract][Full Text] [Related]
60. Cervical cancer screening varies by HPV vaccination status among a National Cohort of privately insured young women in the United States 2006-2016.
Ba DM; McCall-Hosenfeld JS; Ssentongo P; Chinchilli VM; Agbese E; Liu G; Leslie DL; Du P
Medicine (Baltimore); 2021 Oct; 100(41):e27457. PubMed ID: 34731120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]